Print
Email
Print Edition StoriesWednesday, November 18, 2009
Knome targets researchers with new genomic service
By Mass High Tech staff
MHT's Galen Moore: Honoring innovation in New England
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
Personal genomics developer Knome Inc. today claimed that release of a new human genome sequencing and data processing service for researchers will help to bring about thousands of sequencings next year.
Cambridge-based Knome unveiled its KnomeDiscovery, saying that it is a one-stop service that bundles more affordable research-tailored access to sequencing platforms with data management and analysis tools.
The company said that KnomeDiscovery will help individual research groups leverage Knome’s existing sequencing platform and the firm’s experience in whole genome and exome analysis. The service targets two types of researchers. Knome is aiming at researchers with expertise in medical genomics who want to streamline data management and preliminary analysis in the expected mass sequencing projects, as well as clinically trained researchers with extensive expertise in specific diseases, for whom mass sequencing approaches are novel and unfamiliar tools.
Knome said that pricing for KnomeDISCOVERY starts at less than $12,000 per sample, with turn-around in as little as eight weeks.
Knome, founded in 2007 by Harvard University genetics researcher George Church, offers personal genomics for individuals, allowing individuals to understand their own DNA at prices ranging from $19,500 to $68,500.
Earlier this year, Knome teamed up with SeqWright, of Houston, Texas, to provide genomic analysis through a federally approved laboratory for clinical testing. SeqWright is certified by Clinical Laboratory Improvement Amendments (CLIA) to meet federal standards in clinical sample processing.
RSS Feeds
Comments
Please Login/Register to post comments.
No comments have been added or approved.